| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 10 | FR 1 | 99.91 |
| Antibiotic Use and Resistance | Lifetime | 9 | FR 1 | 99.89 |
| Pneumonia and Respiratory Infections | Lifetime | 23 | FR 3 | 99.81 |
| Antibiotic Resistance in Bacteria | Lifetime | 57 | FR 5 | 99.76 |
| Analytical Methods in Pharmaceuticals | Lifetime | 43 | FR 1 | 98.99 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 60 | FR 4 | 99.56 |
| Sepsis Diagnosis and Treatment | Lifetime | 95 | FR 11 | 99.49 |
| Acute Kidney Injury Research | Lifetime | 53 | FR 2 | 99.17 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 186 | FR 10 | 99.10 |
| Anesthesia and Sedative Agents | Lifetime | 231 | FR 9 | 98.56 |
| Poisoning and overdose treatments | Lifetime | 70 | FR 4 | 98.17 |
| Hemodynamic Monitoring and Therapy | Lifetime | 441 | FR 30 | 97.56 |
| Central Venous Catheters and Hemodialysis | Lifetime | 408 | FR 21 | 97.17 |
| Antifungal resistance and susceptibility | Lifetime | 610 | FR 34 | 97.04 |
| Mechanical Circulatory Support Devices | Lifetime | 882 | FR 27 | 96.86 |
| Neutropenia and Cancer Infections | Lifetime | 647 | FR 45 | 94.89 |
| Nosocomial Infections in ICU | Lifetime | 583 | FR 71 | 94.73 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 4 | FR 1 | 99.68 |
| Antibiotic Use and Resistance | 2021-2025 | 10 | FR 1 | 99.40 |
| Pneumonia and Respiratory Infections | 2021-2025 | 16 | FR 2 | 99.24 |
| Antibiotic Resistance in Bacteria | 2021-2025 | 49 | FR 2 | 99.13 |
| Anesthesia and Sedative Agents | 2021-2025 | 81 | FR 2 | 95.38 |
| Bacterial Identification and Susceptibility Testing | 2021-2025 | 103 | FR 7 | 96.10 |
| Antifungal resistance and susceptibility | 2021-2025 | 130 | FR 7 | 97.02 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 236 | FR 19 | 96.06 |
| Pharmaceutical studies and practices | 2021-2025 | 121 | FR 4 | 92.34 |
| Antimicrobial Resistance in Staphylococcus | 2021-2025 | 182 | FR 7 | 93.30 |
| Central Venous Catheters and Hemodialysis | 2021-2025 | 193 | FR 11 | 91.84 |
| Urinary Tract Infections Management | 2021-2025 | 249 | FR 8 | 89.89 |
| Acute Kidney Injury Research | 2021-2025 | 530 | FR 16 | 83.52 |
| Surgical site infection prevention | 2021-2025 | 463 | FR 9 | 74.21 |
| Neutropenia and Cancer Infections | 2021-2025 | 675 | FR 42 | 73.15 |
| Nosocomial Infections in ICU | 2021-2025 | 782 | FR 112 | 70.63 |
| Analytical Methods in Pharmaceuticals | 2021-2025 | 801 | FR 1 | 66.81 |
| Patient Safety and Medication Errors | 2021-2025 | 863 | FR 7 | 64.19 |
